GETI.B

186.85

-1.03%↓

EKTA.B

57.55

-0.26%↓

ATT

101.8

0%↓

AMBEA

134

+0.37%↑

ARJOB

25.24

-0.55%↓

GETI.B

186.85

-1.03%↓

EKTA.B

57.55

-0.26%↓

ATT

101.8

0%↓

AMBEA

134

+0.37%↑

ARJOB

25.24

-0.55%↓

GETI.B

186.85

-1.03%↓

EKTA.B

57.55

-0.26%↓

ATT

101.8

0%↓

AMBEA

134

+0.37%↑

ARJOB

25.24

-0.55%↓

GETI.B

186.85

-1.03%↓

EKTA.B

57.55

-0.26%↓

ATT

101.8

0%↓

AMBEA

134

+0.37%↑

ARJOB

25.24

-0.55%↓

GETI.B

186.85

-1.03%↓

EKTA.B

57.55

-0.26%↓

ATT

101.8

0%↓

AMBEA

134

+0.37%↑

ARJOB

25.24

-0.55%↓

Home・Список акций・Orexo AB

O
Orexo AB

Закрыт

22.4 -3.45

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

Макс.

23.6

Ключевые показатели
By Trading Economics
Доход	-68M -116M
Продажи	-115M 3.3M
Прибыль на акцию	20.884
Рентабельность продаж	-3,503.03
Сотрудники	72
EBITDA	-262M -272M

Дивиденды
By Dow Jones
Следующий отчет о доходах	28 апр. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-224M 810M
Предыдущая цена открытия	25.85
Предыдущая цена закрытия	22.4

Orexo AB График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

18 мар. 2026 г., 22:51 UTC

Отчет

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

18 мар. 2026 г., 21:40 UTC

Приобретения, слияния, поглощения

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

18 мар. 2026 г., 20:31 UTC

Отчет

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

18 мар. 2026 г., 23:49 UTC

Обсуждения рынка

Главные новостные события

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

18 мар. 2026 г., 23:31 UTC

Обсуждения рынка

Gold Rises on Likely Technical Recovery -- Market Talk

18 мар. 2026 г., 22:49 UTC

Обсуждения рынка

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

18 мар. 2026 г., 22:41 UTC

Обсуждения рынка

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

18 мар. 2026 г., 22:36 UTC

Отчет

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

18 мар. 2026 г., 22:24 UTC

Отчет

AIA Group Announces New Share Buyback of $1.7B >1299.HK

18 мар. 2026 г., 22:23 UTC

Отчет

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

18 мар. 2026 г., 22:23 UTC

Отчет

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

18 мар. 2026 г., 21:58 UTC

Отчет

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

18 мар. 2026 г., 21:55 UTC

Обсуждения рынка

Отчет

Global Equities Roundup: Market Talk

18 мар. 2026 г., 21:55 UTC

Обсуждения рынка

Отчет

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

18 мар. 2026 г., 21:40 UTC

Обсуждения рынка

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

18 мар. 2026 г., 21:16 UTC

Обсуждения рынка

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

18 мар. 2026 г., 21:00 UTC

Главные новостные события

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

18 мар. 2026 г., 20:58 UTC

Отчет

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

18 мар. 2026 г., 20:41 UTC

Отчет

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 мар. 2026 г., 20:29 UTC

Отчет

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 мар. 2026 г., 20:25 UTC

Отчет

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 мар. 2026 г., 20:17 UTC

Отчет

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

18 мар. 2026 г., 20:14 UTC

Обсуждения рынка

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

18 мар. 2026 г., 20:09 UTC

Отчет

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

18 мар. 2026 г., 20:07 UTC

Отчет

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

18 мар. 2026 г., 20:06 UTC

Отчет

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

18 мар. 2026 г., 20:04 UTC

Отчет

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

18 мар. 2026 г., 20:04 UTC

Отчет

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

18 мар. 2026 г., 20:04 UTC

Отчет

Micron Technology Sees 3Q Gross Margin About 81% >MU

18 мар. 2026 г., 20:03 UTC

Отчет

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Сравнение c конкурентами

Изменение цены

Orexo AB Прогноз

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Orexo AB

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.